Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection
Nick K Jones, Lucy Rivett, Shaun R. Seaman, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis
Caifang Zheng, Weihao Shao, Xiaorui Chen, et al.
International Journal of Infectious Diseases (2021) Vol. 114, pp. 252-260
Open Access | Times Cited: 582
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 19, pp. 1774-1785
Open Access | Times Cited: 571
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review
Ibrahim Mohammed, Areej Nauman, Pradipta Paul, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 281
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
Eurosurveillance (2021) Vol. 26, Iss. 28
Open Access | Times Cited: 117
Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
Yujing Fan, Kwok‐Hung Chan, Ivan Fan‐Ngai Hung
Vaccines (2021) Vol. 9, Iss. 9, pp. 989-989
Open Access | Times Cited: 109
Current Developments and Challenges of mRNA Vaccines
Jinjin Chen, Jianzhu Chen, Qiaobing Xu
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 85-109
Open Access | Times Cited: 74
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
Alexandra B. Hogan, Peter Winskill, Oliver J. Watson, et al.
Vaccine (2021) Vol. 39, Iss. 22, pp. 2995-3006
Open Access | Times Cited: 97
COVID-19 vaccines for low- and middle-income countries
E Choi
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 5, pp. 447-456
Open Access | Times Cited: 77
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status
Sheila Lumley, Gillian Rodger, Bede Constantinides, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 7, pp. 1208-1219
Open Access | Times Cited: 74
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data
Christophe Paris, Sophie Perrin, Stéphanie Hamonic, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1699.e5-1699.e8
Open Access | Times Cited: 59
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
Darius Mostaghimi, Caroline N Valdez, Haleigh Tianna Larson, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. e52-e58
Open Access | Times Cited: 57
Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine
Luca Coppeta, Cristiana Ferrari, Giuseppina Somma, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 141-141
Open Access | Times Cited: 43
A COVID-19 vaccination model for Aotearoa New Zealand
Nicholas Steyn, Michael J. Plank, Rachelle N. Binny, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Indirect Protection by Reducing Transmission: Ending the Pandemic With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination
Aaron Richterman, Eric A. Meyerowitz, Müge Çevik
Open Forum Infectious Diseases (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 48
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
Richard A. Urbanowicz, Theocharis Tsoleridis, Hannah Jackson, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 609
Open Access | Times Cited: 47
Innovations and development of Covid-19 vaccines: A patent review
Ahmed Subeh Alshrari, Shuaibu Abdullahi Hudu, Mohd Imran, et al.
Journal of Infection and Public Health (2021) Vol. 15, Iss. 1, pp. 123-131
Open Access | Times Cited: 44
SARS-CoV-2 Vaccines: Where Are We Now?
Katie L. Flanagan, C. Raina MacIntyre, Peter McIntyre, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 10, pp. 3535-3543
Open Access | Times Cited: 43
A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings
Yot Teerawattananon, Thunyarat Anothaisintawee, Chatkamol Pheerapanyawaranun, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261930-e0261930
Open Access | Times Cited: 29
Understanding COVID-19 dynamics and the effects of interventions in the Philippines: A mathematical modelling study
Jamie M. Caldwell, Elvira P. de Lara-Tuprio, Timothy Robin Y. Teng, et al.
The Lancet Regional Health - Western Pacific (2021) Vol. 14, pp. 100211-100211
Open Access | Times Cited: 36
Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization
Nimrat Khehra, Inderbir Padda, Urooj Jaferi, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 33
COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France
Pierre-Julien Coulaud, Aidan Ablona, Naseeb Bolduc, et al.
Vaccine (2022) Vol. 40, Iss. 16, pp. 2442-2456
Open Access | Times Cited: 24
Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic
Yutong Wang, Ke Zheng, Wenjing Gao, et al.
Medical Review (2022) Vol. 2, Iss. 1, pp. 66-88
Open Access | Times Cited: 23
Effectiveness of COVID‑19 vaccines and their challenges (Review)
Gabriella Marfè, Stefania Perna, Arvind Shukla
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 30
Efficacy of FFP3 respirators for prevention of SARS-CoV-2 infection in healthcare workers
Mark Ferris, Rebecca Ferris, Christopher T. Workman, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 30
Evolution of Responses to COVID-19 and Epidemiological Characteristics in South Korea
Junhwi Jeon, Chang Yong Han, Tobhin Kim, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 7, pp. 4056-4056
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top